Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Twice Weekly Paclitaxel, Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid in the Treatment of Recurrent or Metastatic Esophageal Cancer

NCT00154700 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00154700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00154700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Twice Weekly Paclitaxel, Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid in the Treatment of Recurrent or Metastatic Esophageal Cancer
Lead sponsor
National Taiwan University Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2001
Completion date
July 31, 2005
Enrollment
40
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer